Anavex Life Sciences (AVXL) Tops Q1 EPS by 5c

Anavex Life Sciences (NASDAQ: AVXL) reported Q1 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance